• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ann Med Surg (Lond) . Cross-sectional study on the proportion of smell and taste disturbances in hospitalized COVID-19 patients

tetano

Editor, Senior Moderator
Ann Med Surg (Lond)


. 2021 Nov;71:102909.
doi: 10.1016/j.amsu.2021.102909. Epub 2021 Oct 8.
Cross-sectional study on the proportion of smell and taste disturbances in hospitalized COVID-19 patients


Niken Lestari Poerbonegoro[SUP] 1 [/SUP], Mirta Hediyati Reksodiputro[SUP] 1 [/SUP], Dewi Puspito Sari[SUP] 1 [/SUP], Thalia Mufida[SUP] 2 [/SUP], Muhammad Ade Rahman[SUP] 2 [/SUP], Lupita Adina Reksodiputro[SUP] 2 [/SUP], Sacha Audindra[SUP] 2 [/SUP], Mikhael Yosia[SUP] 2 [/SUP]



Affiliations

Abstract

Background: The number of confirmed Coronavirus Disease-2019 (COVID-19) cases in Indonesia had reached 1.4 million cases from a total population of 270 million. Smell and/or taste disturbances are frequently found as early symptoms of COVID-19 patients. Our study aimed to investigate the proportion and characteristics of anosmia and/or ageusia in COVID-19.
Materials and methods: This cross-sectional study identifies the proportion and severity of smell and taste disturbances in COVID-19 patients. Subjects were recruited by consecutive sampling. All subjects were required to fill in the questionnaire modified from the American Academy of Otolaryngology-Head and Neck Surgery Anosmia Reporting Tool (AAO-HNS ART). Symptoms severity was measured with a numerical rating scale of 0-10; 0-3 is defined as mild, 4-6 as moderate, and 7-10 as severe.
Results: Out of 51 subjects, 34 (66.7%) suffered from smell and/or taste disturbances. Twenty-nine of 34 subjects (85.3%) suffered from smell disturbance, and 24 of 34 subjects (70.5%) suffered from taste disturbance. Severe smell disturbance occurred in 68.9% of subjects, while severe taste disturbance occurred in 50%. The median onset was three days for smell disturbance and four days for taste disturbance after any symptoms of COVID-19.
Conclusion: Smell and/or taste disturbances were early symptoms of COVID-19. These symptoms commonly occurred within the first four days of clinical onset and frequently manifested in severe conditions.

Keywords: Ageusia; Anosmia; COVID-19; Indonesia.
 
Back
Top Bottom